These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17542021)

  • 21. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction.
    Tye CK; Sun CC; Amidon GE
    J Pharm Sci; 2005 Mar; 94(3):465-72. PubMed ID: 15696587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal anisotropy explains structure-mechanics impact on tableting performance of flufenamic acid polymorphs.
    Jain A; Shah HS; Johnson PR; Narang AS; Morris KR; Haware RV
    Eur J Pharm Biopharm; 2018 Nov; 132():83-92. PubMed ID: 30213565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Particle size distribution and evolution in tablet structure during and after compaction.
    Fichtner F; Rasmuson A; Alderborn G
    Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix tablets of carrageenans. I. A compaction study.
    Picker KM
    Drug Dev Ind Pharm; 1999 Mar; 25(3):329-37. PubMed ID: 10071826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational Techniques for Predicting Mechanical Properties of Organic Crystals: A Systematic Evaluation.
    Wang C; Sun CC
    Mol Pharm; 2019 Apr; 16(4):1732-1741. PubMed ID: 30835128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tableting Properties and Compression Models of Labisia pumila Tablets.
    Etti CJ; Yusof YA; Chin NL; Mohd Tahir S
    J Diet Suppl; 2017 Mar; 14(2):132-145. PubMed ID: 27487244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of in-die powder densification parameters in the implementation of process analytical technologies for tablet production on industrial scale.
    Cespi M; Perinelli DR; Casettari L; Bonacucina G; Caporicci G; Rendina F; Palmieri GF
    Int J Pharm; 2014 Dec; 477(1-2):140-7. PubMed ID: 25304091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical Examination of the Phenomenon of Bonding Area - Bonding Strength Interplay in Powder Tableting.
    Osei-Yeboah F; Chang SY; Sun CC
    Pharm Res; 2016 May; 33(5):1126-32. PubMed ID: 26767997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of temperature increase during the tableting of pharmaceutical materials.
    Cespi M; Bonacucina G; Casettari L; Ronchi S; Palmieri GF
    Int J Pharm; 2013 May; 448(1):320-6. PubMed ID: 23518365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium phosphates in pharmaceutical tableting. 2. Comparison of tableting properties.
    Schmidt PC; Herzog R
    Pharm World Sci; 1993 Jun; 15(3):116-22. PubMed ID: 8348107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Larsson A
    J Pharm Sci; 2011 Jan; 100(1):275-83. PubMed ID: 20572053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuning mechanical properties of pharmaceutical crystals with multicomponent crystals: voriconazole as a case study.
    Sanphui P; Mishra MK; Ramamurty U; Desiraju GR
    Mol Pharm; 2015 Mar; 12(3):889-97. PubMed ID: 25587626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of hardness and strength of tablets and their relation to compaction performance of powders.
    Jetzer WE
    J Pharm Pharmacol; 1986 Apr; 38(4):254-8. PubMed ID: 2872288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the identification of slip planes in organic crystals based on attachment energy calculation.
    Sun CC; Kiang YH
    J Pharm Sci; 2008 Aug; 97(8):3456-61. PubMed ID: 17969130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 3-D model: experimental testing of the parameters d, e, and omega and validation of the analysis.
    Picker-Freyer KM
    J Pharm Sci; 2007 May; 96(5):1408-17. PubMed ID: 17455352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming powder mechanical properties by core/shell structure: compressible sand.
    Shi L; Sun CC
    J Pharm Sci; 2010 Nov; 99(11):4458-62. PubMed ID: 20845444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance.
    Kaialy W; Maniruzzaman M; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Dec; 477(1-2):282-93. PubMed ID: 25447824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Revealing the Role of Structural Features in Bulk Mechanical Performance of Ternary Molecular Solids of Isoniazid.
    Yadav JPA; Yadav B; Kumar N; Bansal AK; Jain S
    Mol Pharm; 2018 Nov; 15(11):5252-5262. PubMed ID: 30265542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.